+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cold-chain Pharma Market - Global Forecast 2026-2032- Product Image
Cold-chain Pharma Market - Global Forecast 2026-2032- Product Image
Sale

Cold-chain Pharma Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666010
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cold-chain Pharma Market is projected to reach USD 18.28 Billion in 2026. It is expected to continue growing at a CAGR of 9.39%, reaching USD 31.47 Billion by 2032.

Cold-chain pharma has become a mission-critical pillar of global healthcare logistics as biologics, vaccines, cell and gene therapies, insulin, blood products, clinical trial materials, and temperature-sensitive specialty medicines require tightly controlled handling from manufacture to patient administration. The sector is defined by temperature assurance, validated packaging, Good Distribution Practice-compliant distribution, lane qualification, real-time monitoring, and exception management across refrigerated, frozen, deep-frozen, and cryogenic conditions. Demand for resilient pharmaceutical cold chain logistics is being reinforced by the growing complexity of biologic drug pipelines, wider immunization programs, decentralization of clinical trials, and stricter regulatory scrutiny over product integrity. Executive priorities are shifting from simple cold storage capacity toward end-to-end visibility, digital temperature monitoring, qualified logistics partners, sustainable packaging, and risk-based quality management. In this environment, cold-chain pharma is no longer a back-office logistics function; it is a strategic capability that protects patient safety, reduces product loss, supports regulatory compliance, and enables access to advanced therapies across developed and emerging healthcare systems.

Transformative Shifts in the Cold-Chain Pharma Landscape

The cold-chain pharma landscape is undergoing transformative change as healthcare supply chains adapt to more sensitive therapies, more stringent compliance expectations, and more volatile operating conditions. Biologics and biosimilars require stable temperature control across increasingly globalized routes, while mRNA platforms, specialty injectables, and cell and gene therapies are raising requirements for ultra-low-temperature and cryogenic logistics. Regulatory frameworks such as Good Distribution Practice, pharmacovigilance expectations, serialization, and documented chain of custody are pushing organizations to validate processes, qualify shipping lanes, and maintain auditable temperature records. At the same time, geopolitical disruption, customs complexity, energy cost volatility, and extreme weather events are making contingency planning and route risk assessment essential. Sustainability is also reshaping procurement, with reusable passive packaging, lower-emission transport modes, optimized shipment consolidation, and recyclable insulation materials gaining attention. The industry is moving from reactive temperature excursion management to proactive, sensor-enabled control towers that integrate packaging, transport, storage, quality assurance, and regulatory documentation into a unified operating model.

Cumulative Impact of Artificial Intelligence on Cold-Chain Pharma

Artificial intelligence is increasingly influencing cold-chain pharma by improving predictive visibility, operational resilience, and quality decision-making. AI-enabled analytics can assess historical lane performance, weather patterns, customs delays, carrier reliability, ambient temperature exposure, and packaging qualification data to support route selection and risk scoring before shipment release. Machine learning models help identify early warning signals for temperature excursions, equipment failures, and delayed handoffs, enabling quality teams to intervene before product integrity is compromised. In warehouse and transport operations, AI can support demand-sensitive inventory positioning, dynamic reefer utilization, predictive maintenance for refrigeration assets, and automated exception prioritization. For clinical trial supply chains and high-value biologics, AI-driven orchestration can reduce waste by aligning batch release, patient scheduling, and last-mile delivery windows. However, adoption requires strong data governance, validated digital systems, cybersecurity controls, explainable algorithms, and alignment with GxP expectations. The cumulative impact of AI is the transition of pharmaceutical cold chain management from static compliance documentation to continuous, intelligence-led assurance.

Key Regional Insights Across Cold-Chain Pharma

Asia-Pacific is becoming a crucial cold-chain pharma region due to expanding biologics manufacturing, large-scale vaccination infrastructure, rising specialty medicine use, and the growth of clinical research activity across China, India, Japan, South Korea, Australia, and ASEAN economies. The region’s opportunity is balanced by diverse regulatory environments, long intra-regional transit lanes, humid climates, and varying cold storage maturity, making qualified packaging and temperature visibility essential. North America remains one of the most advanced environments for pharmaceutical cold chain logistics, supported by mature biologics distribution, specialty pharmacy networks, established clinical trial infrastructure, and high adoption of digital monitoring across the United States and Canada, while cross-border flows involving Mexico increase the importance of harmonized documentation and customs readiness. Latin America is strengthening cold-chain capabilities as public immunization programs, private specialty care, and regional pharmaceutical distribution networks expand, though infrastructure gaps, customs delays, and last-mile variability require robust contingency planning, particularly across Brazil and Mexico. Europe benefits from stringent GDP standards, dense multimodal logistics corridors, and high regulatory harmonization across many markets, while Brexit-related documentation, cross-border temperature assurance, and sustainability mandates continue to shape operating models. The Middle East is positioning itself as a strategic air cargo and healthcare logistics hub, with GCC economies investing in temperature-controlled warehousing, airport free zones, and pharmaceutical import infrastructure. Africa presents a high-impact environment for vaccine distribution, essential medicines, and donor-supported healthcare programs, but cold-chain reliability is highly dependent on energy resilience, trained personnel, validated last-mile delivery, and investment in regional storage networks.

Key Economic and Strategic Group Insights

ASEAN is increasingly important for cold-chain pharma due to its expanding healthcare access, regional manufacturing activity, and rising demand for vaccines, insulin, biologics, and specialty medicines; however, island geographies, tropical climates, customs variation, and uneven infrastructure make lane qualification and last-mile temperature control central to success. The GCC is developing into a high-value pharmaceutical logistics gateway, supported by investments in air cargo, healthcare infrastructure, free-zone distribution, and advanced cold storage, with demand shaped by imported specialty medicines and government-led healthcare modernization. The European Union provides one of the most structured cold-chain operating environments through harmonized GDP expectations, strong regulatory oversight, cross-border road freight density, and increasing emphasis on sustainable logistics, making compliance documentation, temperature mapping, and validated transport systems standard requirements. BRICS countries combine large patient populations, expanding domestic pharmaceutical production, and rising biologics adoption, but their cold-chain requirements vary widely due to differences in climate, regulatory enforcement, infrastructure maturity, and rural healthcare access. G7 economies remain influential in setting advanced cold-chain practices because they host sophisticated healthcare systems, mature specialty pharmaceutical distribution, and strong quality assurance expectations. NATO member countries, particularly those in Europe and North America, are relevant to cold-chain pharma through resilient logistics corridors, dual-use infrastructure, emergency preparedness, and cross-border coordination that can support continuity of temperature-sensitive medical supplies during public health emergencies or geopolitical disruption.

Key Country Insights in Cold-Chain Pharma

The United States leads in advanced cold-chain pharma capabilities due to its large specialty medicine ecosystem, biologics distribution networks, clinical trial activity, and broad use of real-time monitoring, while Canada’s dispersed population and seasonal temperature extremes make packaging validation and regional distribution planning especially important. Mexico is strengthening its role in North American pharmaceutical logistics through nearshoring, manufacturing activity, and cross-border trade, although customs coordination and lane reliability remain critical. Brazil anchors Latin American demand for vaccine distribution, biologics, and specialty therapies, with infrastructure differences across regions requiring careful network design. In Europe, the United Kingdom continues to emphasize compliant pharmaceutical distribution after Brexit-related trade changes, Germany remains a central logistics and manufacturing hub with strong GDP discipline, France supports significant healthcare and vaccine distribution activity, Italy and Spain combine domestic pharmaceutical production with growing specialty medicine demand, and Russia’s vast geography and climatic extremes increase the need for resilient cold storage and long-distance temperature assurance. In Asia-Pacific, China’s expanding biologics production, vaccine capabilities, and healthcare modernization are strengthening domestic cold-chain requirements, while India’s vaccine manufacturing base, clinical research activity, and growing biologics use intensify the need for reliable refrigerated and frozen distribution. Japan’s highly regulated healthcare system and advanced quality culture support stringent cold-chain compliance, Australia’s geography requires robust national distribution planning across long distances, and South Korea’s biologics manufacturing strength and digital infrastructure support sophisticated temperature-controlled logistics for domestic and export markets.

Actionable Recommendations for Cold-Chain Pharma Leaders

Industry leaders should treat cold-chain pharma as an integrated quality and risk management discipline rather than a transport procurement category. Priority actions include validating every critical lane, mapping temperature risk by season and route, qualifying packaging for real-world transit conditions, and establishing clear standard operating procedures for excursions, customs delays, and handoff failures. Organizations should invest in real-time temperature and location monitoring, control tower visibility, predictive analytics, and interoperable data systems that support auditable compliance. Supplier qualification should assess not only cost and coverage but also GDP maturity, staff training, equipment calibration, contingency capacity, cybersecurity, and documented corrective action performance. Leaders should also build resilience through dual routing, backup storage, emergency power, diversified carrier networks, and local contingency inventories for critical medicines. Sustainability goals should be embedded into cold-chain design through reusable shippers, optimized payload density, lower-emission transport choices where feasible, and packaging lifecycle assessments. For high-value biologics, cell and gene therapies, and clinical trial materials, cross-functional coordination between quality, supply chain, regulatory, manufacturing, and patient services is essential to protect product integrity and treatment continuity.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, publicly available, and industry-recognized sources related to pharmaceutical cold chain logistics, healthcare supply chains, regulatory compliance, and temperature-sensitive medicine distribution. The methodology emphasizes qualitative triangulation across regulatory guidance, public health logistics documentation, pharmaceutical distribution standards, customs and trade considerations, infrastructure assessments, clinical supply chain practices, and technology adoption patterns. Insights are validated by comparing recurring themes across multiple credible source categories, including health authorities, logistics standards bodies, trade documentation, peer-reviewed supply chain literature, and public policy materials. The analysis excludes market sizing, market share, and forecasting, and instead focuses on operational drivers, regional dynamics, compliance requirements, technology implications, and strategic actions. The framework prioritizes evidence-based interpretation of cold-chain requirements across refrigerated, frozen, ultra-low-temperature, and cryogenic logistics, with attention to quality assurance, resilience, sustainability, and digital transformation.

Conclusion

Cold-chain pharma is entering a new phase defined by biologics growth, stricter compliance expectations, digital visibility, AI-supported risk management, and the need for resilient global healthcare logistics. The ability to maintain product integrity across complex routes is directly linked to patient safety, regulatory confidence, and access to advanced therapies. Regional and country-level differences in infrastructure, climate, regulation, and healthcare delivery require tailored cold-chain strategies rather than one-size-fits-all distribution models. Organizations that combine validated processes, real-time monitoring, qualified partners, sustainable packaging, and proactive contingency planning will be better positioned to manage temperature-sensitive medicines in an increasingly demanding environment. As pharmaceutical portfolios become more specialized and supply chains face greater disruption, cold-chain excellence will remain a core differentiator for reliable, compliant, and patient-centered healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cold-chain Pharma Market, by Product Type
7.1. Introduction
7.2. Biologics
7.2.1. Monoclonal Antibodies
7.2.2. Plasma-Derived Therapeutics
7.2.3. Recombinant Proteins & Enzymes
7.3. Blood & Plasma Products
7.3.1. Coagulation Factors
7.3.2. Immunoglobulins
7.4. Cell & Gene Therapies
7.4.1. Allogeneic Cell Therapies
7.4.2. Autologous Cell Therapies
7.4.3. Gene Therapies
7.5. Clinical Trial Materials
7.5.1. Ancillaries & Kits
7.5.2. Investigational Medicinal Products
7.6. Insulins & Hormones
7.6.1. GLP-1 & Other Peptide Hormones
7.6.2. Insulin
7.7. Specialty Pharmaceuticals
7.7.1. Fertility & Reproductive Medicines
7.7.2. Specialty Injectables
7.8. Vaccines
7.8.1. Pandemic & Emerging Vaccines
7.8.1.1. mRNA Vaccines
7.8.1.2. Viral Vector Vaccines
7.8.2. Routine Immunization Vaccines
7.8.3. Travel & Specialty Vaccines
8. Cold-chain Pharma Market, by Packaging Type
8.1. Introduction
8.2. Active Packaging
8.3. Passive Packaging
9. Cold-chain Pharma Market, by Temperature Range
9.1. Introduction
9.2. Cryogenic (= -150 °C)
9.2.1. Cryo Packaging
9.2.2. Dry Shipper Transport
9.2.3. LN2 Vapor Storage
9.3. Frozen (-20 To -40 °C)
9.3.1. Packaging
9.3.2. Storage
9.3.3. Transportation
9.4. Refrigerated (2-8 °C)
9.4.1. Packaging
9.4.2. Storage
9.4.3. Transportation
9.5. Ultra-Low (-60 To -86 °C)
9.5.1. Packaging
9.5.2. Storage
9.5.3. Transportation
10. Cold-chain Pharma Market, by Equipment
10.1. Introduction
10.2. Storage Equipment
10.2.1. Cold Rooms & Warehouses
10.2.2. Cryogenic Freezers & LN2 Tanks
10.2.3. Freezers (-20 °C Class)
10.2.4. Pharmaceutical Refrigerators (2-8 °C)
10.2.5. ULT Freezers (-80 °C Class)
10.3. Transport Equipment
10.3.1. Air Cargo Containers (ULDs)
10.3.2. Last-Mile Portable Coolers
10.3.3. Ocean Reefer Containers
10.3.4. Reefer Trucks & Vans
11. Cold-chain Pharma Market, by Service Type
11.1. Introduction
11.2. Clinical Trial Logistics
11.2.1. Ancillary Management
11.2.2. Direct-To-Patient Services
11.2.3. Site Supply And Returns
11.3. Compliance & Quality
11.3.1. Audits & GDP Training
11.3.2. Lane Validation & Risk Assessment
11.3.3. Qualification (IQ/OQ/PQ)
11.4. Storage & Warehousing
11.4.1. Cryogenic Storage
11.4.2. Long-Term GMP Storage
11.5. Transportation
11.5.1. First-Mile Pickup
11.5.2. Last-Mile Delivery
11.5.3. Line-Haul Transport
11.5.4. Reverse Logistics & Returns
12. Cold-chain Pharma Market, by Application
12.1. Introduction
12.2. Clinical Trials
12.3. Commercial Distribution
12.4. Direct-To-Patient/Home Delivery
12.5. Humanitarian & NGO Supply
12.6. Specialty Pharmacy Fulfillment
12.7. Vaccination Campaigns
13. Cold-chain Pharma Market, by End User
13.1. Introduction
13.2. Blood Banks & Plasma Centers
13.3. Clinical Trial Sites & Depots
13.4. CMOs & CDMOs
13.5. CROs
13.6. Hospitals & Clinics
13.7. Pharma & Biotech Manufacturers
13.7.1. Emerging Biotech
13.7.2. Large Pharmaceutical Companies
13.8. Retail & Specialty Pharmacies
13.9. Vaccination Centers & Public Health Agencies
14. Cold-chain Pharma Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Cold-chain Pharma Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Cold-chain Pharma Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Germany
16.5. United Kingdom
16.6. India
16.7. Japan
16.8. Russia
16.9. Brazil
16.10. Canada
16.11. Italy
16.12. Mexico
16.13. France
16.14. Spain
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Americold Realty Trust, Inc.
18.2. AmerisourceBergen Corporation
18.3. BioCold Technologies S.A.S
18.4. C.H. Robinson Worldwide, Inc.
18.5. Catalent, Inc.
18.6. Clinigen Group PLC
18.7. Conestoga Cold Storage Ltd.
18.8. Continental AG
18.9. CWT Ltd.
18.10. DB Schenker
18.11. DHL International GmbH
18.12. DSV A/S
18.13. Emergent Cold LatAm Management LLC
18.14. FedEx Corporation
18.15. FreezPak Logistics
18.16. HCL Technologies Limited
18.17. Helapet ltd.
18.18. Interstate Cold Storage, Inc.
18.19. JWD InfoLogistics Public Co. Ltd.
18.20. Keppel Telecommunications & Transportation Ltd,
18.21. Kuehne + Nagel Management AG
18.22. Lineage, Inc.
18.23. Mærsk A/S
18.24. NewCold Coöperatief UA
18.25. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
18.26. SCG Logistics Management Co Ltd.
18.27. Tiong Nam Logistics Holdings Berhad
18.28. United Parcel Service, Inc.
18.29. Ych Group
18.30. Yusen Logistics Group
19. Key Experts
List of Figures
FIGURE 1. Global Cold-chain Pharma Market, Years Considered for the Study
FIGURE 2. Global Cold-chain Pharma Market, Research Design
FIGURE 3. Global Cold-chain Pharma Market, Research Framework
FIGURE 4. Global Cold-chain Pharma Market, Data Triangulation
FIGURE 5. Global Cold-chain Pharma Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cold-chain Pharma Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Cold-chain Pharma Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cold-chain Pharma Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 9. Global Cold-chain Pharma Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cold-chain Pharma Market Size, by Temperature Range, 2025 vs 2032 (%)
FIGURE 11. Global Cold-chain Pharma Market Size, by Temperature Range, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cold-chain Pharma Market Size, by Equipment, 2025 vs 2032 (%)
FIGURE 13. Global Cold-chain Pharma Market Size, by Equipment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cold-chain Pharma Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 15. Global Cold-chain Pharma Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cold-chain Pharma Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Cold-chain Pharma Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cold-chain Pharma Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Cold-chain Pharma Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Cold-chain Pharma Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Cold-chain Pharma Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Cold-chain Pharma Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Cold-chain Pharma Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Cold-chain Pharma Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Cold-chain Pharma Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Cold-chain Pharma Market Segmentation & Coverage
TABLE 2. Global Cold-chain Pharma Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cold-chain Pharma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Plasma-Derived Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Plasma-Derived Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Plasma-Derived Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Recombinant Proteins & Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Recombinant Proteins & Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Recombinant Proteins & Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Blood & Plasma Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Blood & Plasma Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Blood & Plasma Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Coagulation Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Coagulation Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Coagulation Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Immunoglobulins Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Immunoglobulins Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Immunoglobulins Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cell & Gene Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cell & Gene Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cell & Gene Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Allogeneic Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Allogeneic Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Allogeneic Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Autologous Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Autologous Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Autologous Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Gene Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Gene Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Gene Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Clinical Trial Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Clinical Trial Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Clinical Trial Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ancillaries & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ancillaries & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ancillaries & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Investigational Medicinal Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Investigational Medicinal Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Investigational Medicinal Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Insulins & Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Insulins & Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Insulins & Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global GLP-1 & Other Peptide Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global GLP-1 & Other Peptide Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global GLP-1 & Other Peptide Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Insulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Insulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Insulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Specialty Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Specialty Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Specialty Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Fertility & Reproductive Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Fertility & Reproductive Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Fertility & Reproductive Medicines Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Specialty Injectables Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Specialty Injectables Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Specialty Injectables Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Pandemic & Emerging Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Pandemic & Emerging Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Pandemic & Emerging Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global mRNA Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global mRNA Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global mRNA Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Viral Vector Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Viral Vector Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Viral Vector Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Routine Immunization Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Routine Immunization Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Routine Immunization Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Travel & Specialty Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Travel & Specialty Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Travel & Specialty Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Cold-chain Pharma Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 83. Global Active Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Active Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Active Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Passive Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Passive Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Passive Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Cold-chain Pharma Market Size, by Temperature Range, 2017-2032 (USD Million)
TABLE 90. Global Cryogenic (= -150 °C) Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Cryogenic (= -150 °C) Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Cryogenic (= -150 °C) Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Cryo Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Cryo Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Cryo Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Dry Shipper Transport Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Dry Shipper Transport Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Dry Shipper Transport Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global LN2 Vapor Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global LN2 Vapor Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global LN2 Vapor Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Frozen (-20 To -40 °C) Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Frozen (-20 To -40 °C) Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Frozen (-20 To -40 °C) Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Transportation Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Transportation Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Transportation Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Refrigerated (2-8 °C) Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Refrigerated (2-8 °C) Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Refrigerated (2-8 °C) Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Transportation Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Transportation Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Transportation Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Ultra-Low (-60 To -86 °C) Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Ultra-Low (-60 To -86 °C) Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Ultra-Low (-60 To -86 °C) Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Transportation Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Transportation Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Transportation Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Cold-chain Pharma Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 139. Global Storage Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Storage Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Storage Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Cold Rooms & Warehouses Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Cold Rooms & Warehouses Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Cold Rooms & Warehouses Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Cryogenic Freezers & LN2 Tanks Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Cryogenic Freezers & LN2 Tanks Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Cryogenic Freezers & LN2 Tanks Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Freezers (-20 °C Class) Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Freezers (-20 °C Class) Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Freezers (-20 °C Class) Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Pharmaceutical Refrigerators (2-8 °C) Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Pharmaceutical Refrigerators (2-8 °C) Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Pharmaceutical Refrigerators (2-8 °C) Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global ULT Freezers (-80 °C Class) Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global ULT Freezers (-80 °C Class) Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global ULT Freezers (-80 °C Class) Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Transport Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Transport Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Transport Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Air Cargo Containers (ULDs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Air Cargo Containers (ULDs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Air Cargo Containers (ULDs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Last-Mile Portable Coolers Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Last-Mile Portable Coolers Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Last-Mile Portable Coolers Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Ocean Reefer Containers Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Ocean Reefer Containers Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Ocean Reefer Containers Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Reefer Trucks & Vans Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Reefer Trucks & Vans Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Reefer Trucks & Vans Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Cold-chain Pharma Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 173. Global Clinical Trial Logistics Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Clinical Trial Logistics Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Clinical Trial Logistics Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Ancillary Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Ancillary Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Ancillary Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Direct-To-Patient Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Direct-To-Patient Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Direct-To-Patient Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Site Supply And Returns Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Site Supply And Returns Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Site Supply And Returns Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Compliance & Quality Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Global Compliance & Quality Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. Global Compliance & Quality Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. Global Audits & GDP Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Global Audits & GDP Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. Global Audits & GDP Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. Global Lane Validation & Risk Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Global Lane Validation & Risk Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. Global Lane Validation & Risk Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 194. Global Qualification (IQ/OQ/PQ) Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Global Qualification (IQ/OQ/PQ) Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. Global Qualification (IQ/OQ/PQ) Market Size, by Country, 2017-2032 (USD Million)
TABLE 197. Global Storage & Warehousing Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. Global Storage & Warehousing Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. Global Storage & Warehousing Market Size, by Country, 2017-2032 (USD Million)
TABLE 200. Global Cryogenic Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Global Cryogenic Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. Global Cryogenic Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. Global Long-Term GMP Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Global Long-Term GMP Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. Global Long-Term GMP Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. Global Transportation Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Transportation Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Transportation Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global First-Mile Pickup Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global First-Mile Pickup Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global First-Mile Pickup Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Last-Mile Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Last-Mile Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Last-Mile Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Line-Haul Transport Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Line-Haul Transport Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Line-Haul Transport Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Reverse Logistics & Returns Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Reverse Logistics & Returns Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Reverse Logistics & Returns Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global Cold-chain Pharma Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Global Clinical Trials Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Global Clinical Trials Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. Global Clinical Trials Market Size, by Country, 2017-2032 (USD Million)
TABLE 225. Global Commercial Distribution Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Global Commercial Distribution Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. Global Commercial Distribution Market Size, by Country, 2017-2032 (USD Million)
TABLE 228. Global Direct-To-Patient/Home Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 229. Global Direct-To-Patient/Home Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. Global Direct-To-Patient/Home Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 231. Global Humanitarian & NGO Supply Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Global Humanitarian & NGO Supply Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. Global Humanitarian & NGO Supply Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. Global Specialty Pharmacy Fulfillment Market Size, by Region, 2017-2032 (USD Million)
TABLE 235. Global Specialty Pharmacy Fulfillment Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. Global Specialty Pharmacy Fulfillment Market Size, by Country, 2017-2032 (USD Million)
TABLE 237. Global Vaccination Campaigns Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Global Vaccination Campaigns Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. Global Vaccination Campaigns Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. Global Cold-chain Pharma Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Global Blood Banks & Plasma Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 242. Global Blood Banks & Plasma Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. Global Blood Banks & Plasma Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 244. Global Clinical Trial Sites & Depots Market Size, by Region, 2017-2032 (USD Million)
TABLE 245. Global Clinical Trial Sites & Depots Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. Global Clinical Trial Sites & Depots Market Size, by Country, 2017-2032 (USD Million)
TABLE 247. Global CMOs & CDMOs Market Size, by Region, 2017-2032 (USD Million)
TABLE 248. Global CMOs & CDMOs Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. Global CMOs & CDMOs Market Size, by Country, 2017-2032 (USD Million)
TABLE 250. Global CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Global CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. Global CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 253. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 254. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 256. Global Pharma & Biotech Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 257. Global Pharma & Biotech Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. Global Pharma & Biotech Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 259. Global Emerging Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 260. Global Emerging Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. Global Emerging Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 262. Global Large Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 263. Global Large Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 264. Global Large Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 265. Global Retail & Specialty Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 266. Global Retail & Specialty Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. Global Retail & Specialty Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 268. Global Vaccination Centers & Public Health Agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 269. Global Vaccination Centers & Public Health Agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. Global Vaccination Centers & Public Health Agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 271. Global Cold-chain Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 272. Asia-Pacific Cold-chain Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 273. Asia-Pacific Cold-chain Pharma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific Cold-chain Pharma Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific Cold-chain Pharma Market Size, by Blood & Plasma Products, 2017-2032 (USD Million)
TABLE 276. Asia-Pacific Cold-chain Pharma Market Size, by Cell & Gene Therapies, 2017-2032 (USD Million)
TABLE 277. Asia-Pacific Cold-chain Pharma Market Size, by Clinical Trial Materials, 2017-2032 (USD Million)
TABLE 278. Asia-Pacific Cold-chain Pharma Market Size, by Insulins & Hormones, 2017-2032 (USD Million)
TABLE 279. Asia-Pacific Cold-chain Pharma Market Size, by Specialty Pharmaceuticals, 2017-2032 (USD Million)
TABLE 280. Asia-Pacific Cold-chain Pharma Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 281. Asia-Pacific Cold-chain Pharma Market Size, by Pandemic & Emerging Vaccines, 2017-2032 (USD Million)
TABLE 282. Asia-Pacific Cold-chain Pharma Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 283. Asia-Pacific Cold-chain Pharma Market Size, by Temperature Range, 2017-2032 (USD Million)
TABLE 284. Asia-Pacific Cold-chain Pharma Market Size, by Cryogenic (= -150 °C), 2017-2032 (USD Million)
TABLE 285. Asia-Pacific Cold-chain Pharma Market Size, by Frozen (-20 To -40 °C), 2017-2032 (USD Million)
TABLE 286. Asia-Pacific Cold-chain Pharma Market Size, by Refrigerated (2-8 °C), 2017-2032 (USD Million)
TABLE 287. Asia-Pacific Cold-chain Pharma Market Size, by Ultra-Low (-60 To -86 °C), 2017-2032 (USD Million)
TABLE 288. Asia-Pacific Cold-chain Pharma Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 289. Asia-Pacific Cold-chain Pharma Market Size, by Storage Equipment, 2017-2032 (USD Million)
TABLE 290. Asia-Pacific Cold-chain Pharma Market Size, by Transport Equipment, 2017-2032 (USD Million)
TABLE 291. Asia-Pacific Cold-chain Pharma Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 292. Asia-Pacific Cold-chain Pharma Market Size, by Clinical Trial Logistics, 2017-2032 (USD Million)
TABLE 293. Asia-Pacific Cold-chain Pharma Market Size, by Compliance & Quality, 2017-2032 (USD Million)
TABLE 294. Asia-Pacific Cold-chain Pharma Market Size, by Storage & Warehousing, 2017-2032 (USD Million)
TABLE 295. Asia-Pacific Cold-chain Pharma Market Size, by Transportation, 2017-2032 (USD Million)
TABLE 296. Asia-Pacific Cold-chain Pharma Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Asia-Pacific Cold-chain Pharma Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Asia-Pacific Cold-chain Pharma Market Size, by Pharma & Biotech Manufacturers, 2017-2032 (USD Million)
TABLE 299. North America Cold-chain Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 300. North America Cold-chain Pharma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. North America Cold-chain Pharma Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 302. North America Cold-chain Pharma Market Size, by Blood & Plasma Products, 2017-2032 (USD Million)
TABLE 303. North America Cold-chain Pharma Market Size, by Cell & Gene Therapies, 2017-2032 (USD Million)
TABLE 304. North America Cold-chain Pharma Market Size, by Clinical Trial Materials, 2017-2032 (USD Million)
TABLE 305. North America Cold-chain Pharma Market Size, by Insulins & Hormones, 2017-2032 (USD Million)
TABLE 306. North America Cold-chain Pharma Market Size, by Specialty Pharmaceuticals, 2017-2032 (USD Million)
TABLE 307. North America Cold-chain Pharma Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 308. North America Cold-chain Pharma Market Size, by Pandemic & Emerging Vaccines, 2017-2032 (USD Million)
TABLE 309. North America Cold-chain Pharma Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 310. North America Cold-chain Pharma Market Size, by Temperature Range, 2017-2032 (USD Million)
TABLE 311. North America Cold-chain Pharma Market Size, by Cryogenic (= -150 °C), 2017-2032 (USD Million)
TABLE 312. North America Cold-chain Pharma Market Size, by Frozen (-20 To -40 °C), 2017-2032 (USD Million)
TABLE 313. North America Cold-chain Pharma Market Size, by Refrigerated (2-8 °C), 2017-2032 (USD Million)
TABLE 314. North America Cold-chain Pharma Market Size, by Ultra-Low (-60 To -86 °C), 2017-2032 (USD Million)
TABLE 315. North America Cold-chain Pharma Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 316. North America Cold-chain Pharma Market Size, by Storage Equipment, 2017-2032 (USD Million)
TABLE 317. North America Cold-chain Pharma Market Size, by Transport Equipment, 2017-2032 (USD Million)
TABLE 318. North America Cold-chain Pharma Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 319. North America Cold-chain Pharma Market Size, by Clinical Trial Logistics, 2017-2032 (USD Million)
TABLE 320. North America Cold-chain Pharma Market Size, by Compliance & Quality, 2017-2032 (USD Million)
TABLE 321. North America Cold-chain Pharma Market Size, by Storage & Warehousing, 2017-2032 (USD Million)
TABLE 322. North America Cold-chain Pharma Market Size, by Transportation, 2017-2032 (USD Million)
TABLE 323. North America Cold-chain Pharma Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. North America Cold-chain Pharma Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. North America Cold-chain Pharma Market Size, by Pharma & Biotech Manufacturers, 2017-2032 (USD Million)
TABLE 326. Latin America Cold-chain Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 327. Latin America Cold-chain Pharma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 328. Latin America Cold-chain Pharma Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 329. Latin America Cold-chain Pharma Market Size, by Blood & Plasma Products, 2017-2032 (USD Million)
TABLE 330. Latin America Cold-chain Pharma Market Size, by Cell & Gene Therapies, 2017-2032 (USD Million)
TABLE 331. Latin America Cold-chain Pharma Market Size, by Clinical Trial Materials, 2017-2032 (USD Million)
TABLE 332. Latin America Cold-chain Pharma Market Size, by Insulins & Hormones, 2017-2032 (USD Million)
TABLE 333. Latin America Cold-chain Pharma Market Size, by Specialty Pharmaceuticals, 2017-2032 (USD Million)
TABLE 334. Latin America Cold-chain Pharma Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 335. Latin America Cold-chain Pharma Market Size, by Pandemic & Emerging Vaccines, 2017-2032 (USD Million)
TABLE 336. Latin America Cold-chain Pharma Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 337. Latin America Cold-chain Pharma Market Size, by Temperature Range, 2017-2032 (USD Million)
TABLE 338. Latin America Cold-chain Pharma Market Size, by Cryogenic (= -150 °C), 2017-2032 (USD Million)
TABLE 339. Latin America Cold-chain Pharma Market Size, by Frozen (-20 To -40 °C), 2017-2032 (USD Million)
TABLE 340. Latin America Cold-chain Pharma Market Size, by Refrigerated (2-8 °C), 2017-2032 (USD Million)
TABLE 341. Latin America Cold-chain Pharma Market Size, by Ultra-Low (-60 To -86 °C), 2017-2032 (USD Million)
TABLE 342. Latin America Cold-chain Pharma Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 343. Latin America Cold-chain Pharma Market Size, by Storage Equipment, 2017-2032 (USD Million)
TABLE 344. Latin America Cold-chain Pharma Market Size, by Transport Equipment, 2017-2032 (USD Million)
TABLE 345. Latin America Cold-chain Pharma Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 346. Latin America Cold-chain Pharma Market Size, by Clinical Trial Logistics, 2017-2032 (USD Million)
TABLE 347. Latin America Cold-chain Pharma Market Size, by Compliance & Quality, 2017-2032 (USD Million)
TABLE 348. Latin America Cold-chain Pharma Market Size, by Storage & Warehousing, 2017-2032 (USD Million)
TABLE 349. Latin America Cold-chain Pharma Market Size, by Transportation, 2017-2032 (USD Million)
TABLE 350. Latin America Cold-chain Pharma Market Size, by Application, 2017-2032 (USD Million)
TABLE 351. Latin America Cold-chain Pharma Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. Latin America Cold-chain Pharma Market Size, by Pharma & Biotech Manufacturers, 2017-2032 (USD Million)
TABLE 353. Europe Cold-chain Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 354. Europe Cold-chain Pharma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 355. Europe Cold-chain Pharma Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 356. Europe Cold-chain Pharma Market Size, by Blood & Plasma Products, 2017-2032 (USD Million)
TABLE 357. Europe Cold-chain Pharma Market Size, by Cell & Gene Therapies, 2017-2032 (USD Million)
TABLE 358. Europe Cold-chain Pharma Market Size, by Clinical Trial Materials, 2017-2032 (USD Million)
TABLE 359. Europe Cold-chain Pharma Market Size, by Insulins & Hormones, 2017-2032 (USD Million)
TABLE 360. Europe Cold-chain Pharma Market Size, by Specialty Pharmaceuti

Companies Mentioned

  • Americold Realty Trust, Inc.
  • AmerisourceBergen Corporation
  • BioCold Technologies S.A.S
  • C.H. Robinson Worldwide, Inc.
  • Catalent, Inc.
  • Clinigen Group PLC
  • Conestoga Cold Storage Ltd.
  • Continental AG
  • CWT Ltd.
  • DB Schenker
  • DHL International GmbH
  • DSV A/S
  • Emergent Cold LatAm Management LLC
  • FedEx Corporation
  • FreezPak Logistics
  • HCL Technologies Limited
  • Helapet ltd.
  • Interstate Cold Storage, Inc.
  • JWD InfoLogistics Public Co. Ltd.
  • Keppel Telecommunications & Transportation Ltd,
  • Kuehne + Nagel Management AG
  • Lineage, Inc.
  • Mærsk A/S
  • NewCold Coöperatief UA
  • OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • SCG Logistics Management Co Ltd.
  • Tiong Nam Logistics Holdings Berhad
  • United Parcel Service, Inc.
  • Ych Group
  • Yusen Logistics Group

Table Information

Report AttributeDetails
No. of Pages185
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.28 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.47 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Cold Chain Market - Global Forecast 2026-2032 - Product Image

Cold Chain Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Cold Chain Logistics Market - Global Forecast 2026-2032 - Product Image

Cold Chain Logistics Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Cold Chain Logistics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Cold Chain Logistics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 169 Pages
  • Global
From
Healthcare Cold Chain Logistics - Global Strategic Business Report - Product Image

Healthcare Cold Chain Logistics - Global Strategic Business Report

  • Report
  • 488 Pages
  • Global
From
Healthcare Cold Chain - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Healthcare Cold Chain - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From

About the Cold Chain Market

The Cold Chain Pharmaceutical market is a specialized sector of the Pharmaceutical Packaging industry. It involves the storage and transportation of temperature-sensitive pharmaceuticals, such as vaccines, biologics, and other drugs. These products must be kept at a specific temperature range to ensure their efficacy and safety. Cold Chain Pharmaceutical Packaging is designed to maintain the temperature of the product, while also providing protection from external elements. This includes insulation, desiccants, and other materials to ensure the product remains at the desired temperature. The Cold Chain Pharmaceutical market is an important part of the Pharmaceutical Packaging industry, as it ensures the safe and effective delivery of temperature-sensitive products. Companies in this market include Cold Chain Technologies, Pelican BioThermal, Sofrigam, and Sonoco ThermoSafe. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.